InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Maizel Ari. Director active across 1 company, notably Axsome Therapeutics, Inc.. Aggregated, 2 filings have been logged. Split: 0 buy · 1 sell. Total volume traded: €1.2m. History available since 22 April 2026. The latest transaction was disclosed on 22 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations